Author: K. D. Rainsford
Publisher: Springer Science & Business Media
ISBN: 9400912536
Category : Medical
Languages : en
Pages : 331
Book Description
At present we may be at the cross-roads in the therapeutic approaches we have for the treatment of the 100 or more rheumatic conditions. This is be cause we now recognise that although some advances have been made with the development of a large range of non-steroidal and steroidal drugs during the past two decades or so, we now recognise that many, if not all, of these have rather limited effects on many of the disease processes which underlie the manifestations of the various rheumatic states. Advances in molecular bi- 010gy in the past 5-10 years have enabled these tools to be applied extensive ly for developing further our understanding of the rheumatic disease processes. In some cases these molecular tools (e. g. ,),-interferon, interleukin- 2, T-cell antibodies) have been directly employed as therapies themselves. While the outcome from trials with such agents in rheumatoid arthritis in particular has not been as would have been hoped, these results as with cy closporin A and low-dose methotrexate in the therapy of rheumatoid arth ritis have given us important indications for the approach employing what are generally described as "immunomodulators" to control this disease. But this may not be the same type of approach which is desirable for all types of rheumatic conditions. Indeed, even the way which the present range of drugs and other therapies are applied may not be the most effective and safe means of treating different types of arthritic conditions.
New Developments in Antirheumatic Therapy
Author: K. D. Rainsford
Publisher: Springer Science & Business Media
ISBN: 9400912536
Category : Medical
Languages : en
Pages : 331
Book Description
At present we may be at the cross-roads in the therapeutic approaches we have for the treatment of the 100 or more rheumatic conditions. This is be cause we now recognise that although some advances have been made with the development of a large range of non-steroidal and steroidal drugs during the past two decades or so, we now recognise that many, if not all, of these have rather limited effects on many of the disease processes which underlie the manifestations of the various rheumatic states. Advances in molecular bi- 010gy in the past 5-10 years have enabled these tools to be applied extensive ly for developing further our understanding of the rheumatic disease processes. In some cases these molecular tools (e. g. ,),-interferon, interleukin- 2, T-cell antibodies) have been directly employed as therapies themselves. While the outcome from trials with such agents in rheumatoid arthritis in particular has not been as would have been hoped, these results as with cy closporin A and low-dose methotrexate in the therapy of rheumatoid arth ritis have given us important indications for the approach employing what are generally described as "immunomodulators" to control this disease. But this may not be the same type of approach which is desirable for all types of rheumatic conditions. Indeed, even the way which the present range of drugs and other therapies are applied may not be the most effective and safe means of treating different types of arthritic conditions.
Publisher: Springer Science & Business Media
ISBN: 9400912536
Category : Medical
Languages : en
Pages : 331
Book Description
At present we may be at the cross-roads in the therapeutic approaches we have for the treatment of the 100 or more rheumatic conditions. This is be cause we now recognise that although some advances have been made with the development of a large range of non-steroidal and steroidal drugs during the past two decades or so, we now recognise that many, if not all, of these have rather limited effects on many of the disease processes which underlie the manifestations of the various rheumatic states. Advances in molecular bi- 010gy in the past 5-10 years have enabled these tools to be applied extensive ly for developing further our understanding of the rheumatic disease processes. In some cases these molecular tools (e. g. ,),-interferon, interleukin- 2, T-cell antibodies) have been directly employed as therapies themselves. While the outcome from trials with such agents in rheumatoid arthritis in particular has not been as would have been hoped, these results as with cy closporin A and low-dose methotrexate in the therapy of rheumatoid arth ritis have given us important indications for the approach employing what are generally described as "immunomodulators" to control this disease. But this may not be the same type of approach which is desirable for all types of rheumatic conditions. Indeed, even the way which the present range of drugs and other therapies are applied may not be the most effective and safe means of treating different types of arthritic conditions.
Advances in Anti Rheumatic Therapy
Author: Kim D. Rainsford
Publisher: CRC Press
ISBN: 9780849349379
Category : Medical
Languages : en
Pages : 254
Book Description
This work on advances in anti-rheumatic therapy covers topics such as: outcome measures in clinical trials of anti-rheumatic drugs; azapropazone (AZP); the mode of action of glucocorticoids; and clinical trials of oral chondroitin sulphate in the treatment of osteoarthritis.
Publisher: CRC Press
ISBN: 9780849349379
Category : Medical
Languages : en
Pages : 254
Book Description
This work on advances in anti-rheumatic therapy covers topics such as: outcome measures in clinical trials of anti-rheumatic drugs; azapropazone (AZP); the mode of action of glucocorticoids; and clinical trials of oral chondroitin sulphate in the treatment of osteoarthritis.
Rheumatoid Arthritis
Author: John J. Cush
Publisher:
ISBN: 1932610286
Category : Medical
Languages : en
Pages : 368
Book Description
Emphasizes the importance of early intervention in RA with focus on pharmacologic treatment of RA. Detailed information on the various medications employed in treatment, including corticosteroids, NSAIDs DMARDs, biologic agents, and combination therapy is reviewed, including evidence based data on efficacy, safety, side effects, and monitoring requirements. Clinical evaluation is presented, including lab findings, joint scoring, diagnostic criteria, and radiographic outcomes. Surgical options and the management of advanced RA are disussed.
Publisher:
ISBN: 1932610286
Category : Medical
Languages : en
Pages : 368
Book Description
Emphasizes the importance of early intervention in RA with focus on pharmacologic treatment of RA. Detailed information on the various medications employed in treatment, including corticosteroids, NSAIDs DMARDs, biologic agents, and combination therapy is reviewed, including evidence based data on efficacy, safety, side effects, and monitoring requirements. Clinical evaluation is presented, including lab findings, joint scoring, diagnostic criteria, and radiographic outcomes. Surgical options and the management of advanced RA are disussed.
Biologics in Rheumatology
Author: Coziana Ciurtin
Publisher:
ISBN: 9781634853026
Category : HEALTH & FITNESS
Languages : en
Pages : 539
Book Description
Significant progress has been acquired in the treatment of rheumatic conditions with the introduction of biologic therapies, which has enabled better control of disease activity and improved patients' long-term outcome. Apart from several biologic treatments already licensed for use in autoimmune rheumatic conditions, numerous other agents are currently under investigation. This rapid expansion of the therapeutic armamentarium requires a critical analysis of individual biologic options and their clinical indications, in order to facilitate the optimal use of these new therapies. The authors felt that a comprehensive book revisiting all the evidence available regarding the efficacy, cost-effectiveness and health implications of the use of biologics in rheumatology was needed in order to integrate the clinical, ethical and socio-economic aspects related to their use. This book is aimed at specialist doctors, trainees, nurses and health professionals working in the field of rheumatology. It critically appraises the level of evidence behind the use of biologic agents in diverse autoimmune diseases, comprising separate chapters which focus on rheumatoid arthritis, systemic lupus erythematosus, myositis, systemic sclerosis, Sjogren's syndrome, seronegative spondyloarthropathies, psoriatic arthritis and psoriasis, small, medium and large vessel vasculitis, osteoporosis, and interstitial lung disease associated with rheumatic conditions. In addition, the book explores aspects related to the use of biologic agents, such as ethical considerations of consenting patients to take part in clinical trials with biologics, and adolescent and adult rheumatology nurse perspectives related to patients' benefits of biologic therapies. Particular interest is given to the use of biologics during pregnancy and assessment of their infectious risks. A separate chapter explores the off-target benefits associated with the use of anti-TNF therapies. Several chapters include data about cost-effectiveness, and national and international guidelines for the use of biologic agents in different rheumatic conditions.
Publisher:
ISBN: 9781634853026
Category : HEALTH & FITNESS
Languages : en
Pages : 539
Book Description
Significant progress has been acquired in the treatment of rheumatic conditions with the introduction of biologic therapies, which has enabled better control of disease activity and improved patients' long-term outcome. Apart from several biologic treatments already licensed for use in autoimmune rheumatic conditions, numerous other agents are currently under investigation. This rapid expansion of the therapeutic armamentarium requires a critical analysis of individual biologic options and their clinical indications, in order to facilitate the optimal use of these new therapies. The authors felt that a comprehensive book revisiting all the evidence available regarding the efficacy, cost-effectiveness and health implications of the use of biologics in rheumatology was needed in order to integrate the clinical, ethical and socio-economic aspects related to their use. This book is aimed at specialist doctors, trainees, nurses and health professionals working in the field of rheumatology. It critically appraises the level of evidence behind the use of biologic agents in diverse autoimmune diseases, comprising separate chapters which focus on rheumatoid arthritis, systemic lupus erythematosus, myositis, systemic sclerosis, Sjogren's syndrome, seronegative spondyloarthropathies, psoriatic arthritis and psoriasis, small, medium and large vessel vasculitis, osteoporosis, and interstitial lung disease associated with rheumatic conditions. In addition, the book explores aspects related to the use of biologic agents, such as ethical considerations of consenting patients to take part in clinical trials with biologics, and adolescent and adult rheumatology nurse perspectives related to patients' benefits of biologic therapies. Particular interest is given to the use of biologics during pregnancy and assessment of their infectious risks. A separate chapter explores the off-target benefits associated with the use of anti-TNF therapies. Several chapters include data about cost-effectiveness, and national and international guidelines for the use of biologic agents in different rheumatic conditions.
Cumulated Index Medicus
Author:
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 804
Book Description
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 804
Book Description
New Drugs for Rheumatism
Author: Annika Meyers
Publisher: BoD – Books on Demand
ISBN: 3689049644
Category : Medical
Languages : en
Pages : 125
Book Description
Rheumatism is a chronic disease that has a significant impact on the lives of millions of people worldwide. However, in recent decades, medical research has made significant progress in improving treatment options for sufferers. Today, we not only have proven drugs at our disposal, but also completely new therapeutic approaches that are revolutionizing the treatment of rheumatism. The focus is not only on the successes of the past decades, but above all on the pioneering drugs that are currently in clinical research and development. From biologics and Janus kinase inhibitors to personalized therapy approaches: The book provides insights into the variety of therapy options and explains the role played by new approaches such as the blockade of cytokines or the use of targeted kinase inhibitors. It shows how the targeted use of biomarkers allows therapies to be tailored ever more precisely to individual patients and outlines the promising developments that are expected in the coming years. This book offers a well-founded, yet easy-to-understand analysis of current and future possibilities in rheumatism therapy. It shows how modern drugs can help to alleviate the symptoms of rheumatism, improve quality of life and slow down the progression of the disease in the long term. For sufferers and specialists alike, this work is essential reading that not only provides information, but also gives hope for a better future for people with rheumatism.
Publisher: BoD – Books on Demand
ISBN: 3689049644
Category : Medical
Languages : en
Pages : 125
Book Description
Rheumatism is a chronic disease that has a significant impact on the lives of millions of people worldwide. However, in recent decades, medical research has made significant progress in improving treatment options for sufferers. Today, we not only have proven drugs at our disposal, but also completely new therapeutic approaches that are revolutionizing the treatment of rheumatism. The focus is not only on the successes of the past decades, but above all on the pioneering drugs that are currently in clinical research and development. From biologics and Janus kinase inhibitors to personalized therapy approaches: The book provides insights into the variety of therapy options and explains the role played by new approaches such as the blockade of cytokines or the use of targeted kinase inhibitors. It shows how the targeted use of biomarkers allows therapies to be tailored ever more precisely to individual patients and outlines the promising developments that are expected in the coming years. This book offers a well-founded, yet easy-to-understand analysis of current and future possibilities in rheumatism therapy. It shows how modern drugs can help to alleviate the symptoms of rheumatism, improve quality of life and slow down the progression of the disease in the long term. For sufferers and specialists alike, this work is essential reading that not only provides information, but also gives hope for a better future for people with rheumatism.
Index Medicus
Author:
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1812
Book Description
Vols. for 1963- include as pt. 2 of the Jan. issue: Medical subject headings.
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1812
Book Description
Vols. for 1963- include as pt. 2 of the Jan. issue: Medical subject headings.
The Eicosanoids
Author: Peter Curtis-Prior
Publisher: John Wiley & Sons
ISBN: 047002061X
Category : Medical
Languages : en
Pages : 654
Book Description
This comprehensive reference work, updated from the first edition, brings together the knowledge and expertise of contributors from around the world. It includes new topics such as prostaglandin synthetase enzyme, new synthetic eicosanoids, innovative analytical methods, the influence of cytokines in the regulation of synthesis and actions, newer eicosanoids that influence the cardiovascular system, and newly discovered roles in reproduction and interactions with nitric oxide. This book satisfies a surge of interest in prostaglandins—NSAIDS (e.g. aspirin) are the biggest selling drugs of all time, and the field has been refreshed by the advent of new types (selective COX-2 inhibitors, anti-leukotiene drugs).
Publisher: John Wiley & Sons
ISBN: 047002061X
Category : Medical
Languages : en
Pages : 654
Book Description
This comprehensive reference work, updated from the first edition, brings together the knowledge and expertise of contributors from around the world. It includes new topics such as prostaglandin synthetase enzyme, new synthetic eicosanoids, innovative analytical methods, the influence of cytokines in the regulation of synthesis and actions, newer eicosanoids that influence the cardiovascular system, and newly discovered roles in reproduction and interactions with nitric oxide. This book satisfies a surge of interest in prostaglandins—NSAIDS (e.g. aspirin) are the biggest selling drugs of all time, and the field has been refreshed by the advent of new types (selective COX-2 inhibitors, anti-leukotiene drugs).
Early Rheumatoid Arthritis
Author: Paul Emery
Publisher:
ISBN: 9781416027676
Category : Rheumatoid arthritis
Languages : en
Pages : 0
Book Description
This issue covers the latest developments in the understanding of rheumatoid arthritis at the early stage. Treatments such as with newer biologic agents and conventional disease-modifying antirheumatic drugs are reviewed. Also included are articles on imaging modalities as a means of identifying those in the early stages and monitoring response to treatment.
Publisher:
ISBN: 9781416027676
Category : Rheumatoid arthritis
Languages : en
Pages : 0
Book Description
This issue covers the latest developments in the understanding of rheumatoid arthritis at the early stage. Treatments such as with newer biologic agents and conventional disease-modifying antirheumatic drugs are reviewed. Also included are articles on imaging modalities as a means of identifying those in the early stages and monitoring response to treatment.
Rheumatoid Arthritis
Author: E. William St. Clair
Publisher: Lippincott Williams & Wilkins
ISBN: 9780781741491
Category : Medical
Languages : en
Pages : 580
Book Description
This authoritative clinical reference provides comprehensive coverage of all aspects of rheumatoid arthritis. The basics of rheumatoid arthritis are thoroughly covered in order to provide a firm foundation for the main focus of the text: therapy and clinical management of the disease. Practitioners will find detailed information on both pharmacologic and nonpharmacologic courses of management, with special emphasis on the management of pain. More than 100 full-color illustrations provide clear visual support for the concepts in the text. Online references in each chapter, as well as an entire chapter on Web-based information resources, keep this book on the cutting edge of this rapidly evolving field.
Publisher: Lippincott Williams & Wilkins
ISBN: 9780781741491
Category : Medical
Languages : en
Pages : 580
Book Description
This authoritative clinical reference provides comprehensive coverage of all aspects of rheumatoid arthritis. The basics of rheumatoid arthritis are thoroughly covered in order to provide a firm foundation for the main focus of the text: therapy and clinical management of the disease. Practitioners will find detailed information on both pharmacologic and nonpharmacologic courses of management, with special emphasis on the management of pain. More than 100 full-color illustrations provide clear visual support for the concepts in the text. Online references in each chapter, as well as an entire chapter on Web-based information resources, keep this book on the cutting edge of this rapidly evolving field.